Images List Premium Download Classic

Infectious Diseases

Infectious Diseases-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Modulation of antigen immunogenicity by deleting epitopes recognized by nkt cells
Imnate Sarl
January 11, 2018 - N°20180009843

The invention describes a method and compounds for the prevention of immune responses towards allofactors, towards viral vectors used for gene therapy and gene vaccination, towards proteins to which subjects are naturally exposed, towards genetically-modified organisms and towards undesirable effects related to vaccine administration for allergic or infectious diseases.
Enterococcus faecalis and/or enterococcus faecium antigen
Universitätsklinikum Freiburg
January 11, 2018 - N°20180009834

The present invention generally relates to the field of detecting and preventing infectious diseases caused by enterococcus faecalis and/or enterococcus faecium. More specifically, the invention relates to an enterococcus faecalis and/or enterococcus faecium antigen which comprises at least one unit having the following general formula:
Inhibitors of trka kinase
Gvk Biosciences Private Limited
January 11, 2018 - N°20180009781

The present invention is directed to the compounds of formula i which are inhibitors of tropomyosin-related kinase a (trka): formula (i) or steroisomers, tautomers or a pharmaceutically acceptable salts, metabolites, isotopes, solvates or prodrugs thereof, wherein, ra, rb, rc, rd, r1, r2, l and het-ar are as defined herein. These compounds can be used for the preventive and/or therapeutic ...
Infectious Diseases Patent Pack
Download 108+ patent application PDFs
Infectious Diseases Patent Applications
Download 108+ Infectious Diseases-related PDFs
For professional research & prior art discovery
inventor
  • 108+ full patent PDF documents of Infectious Diseases-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Use of prostacyclin antagonists for treating ocular surface nociception
Jenivision Inc.
January 11, 2018 - N°20180008578

The present invention relates generally to the use of compositions and methods for treating nociceptive events that occur on the ocular surface in association with dryness, injury, environmental pollutants, and infectious and non-infectious diseases. Specifically, the present invention is directed to the use of certain compounds for treating for treating ocular pain or ocular discomfort.
Cyclic dinucleotides useful for the treatment of inter alia cancer
Jenivision Inc.
January 04, 2018 - N°20180002369

Or a pharmaceutically acceptable salt and tautomers thereof, compositions, combinations and medicaments containing said compounds and processes for their preparation. The invention also relates to the use of said compounds, combinations, compositions and medicaments, in the treatment of diseases and conditions in which modulation of sting (stimulator of interferon genes) is beneficial, for example inflammation, allergic and autoimmune diseases, infectious ...
Targeted conjugates and particles and formulations thereof
Tarveda Therapeutics, Inc.
January 04, 2018 - N°20180000959

Nanoparticles and microparticles, and pharmaceutical formulations thereof, containing conjugates of an active agent such as a therapeutic, prophylactic, or diagnostic agent attached to a targeting moiety, such as a somatostatin receptor binding moiety, via a linker have been designed. Such nanoparticles and microparticles can provide improved temporospatial delivery of the active agent and/or improved biodistribution. Methods of making the ...
Infectious Diseases Patent Pack
Download 108+ patent application PDFs
Infectious Diseases Patent Applications
Download 108+ Infectious Diseases-related PDFs
For professional research & prior art discovery
inventor
  • 108+ full patent PDF documents of Infectious Diseases-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Method for identifying pathogens of bacterial infectious diseases by using bacteria-derived nanovesicles
Md Healthcare Inc.
December 28, 2017 - N°20170369930

The present invention relates to a method for predicting causative factors (bacteria) of serious bacterial infectious diseases in a clinical sample containing bacteria-derived nano-sized extracellular vesicles, that is, nanovesicles, through the analysis of the genes contained in the nanovesicles. According to the present invention, information on bacteria of serious bacterial infection can be provided, a causative factor of the bacterial ...
Macrocyclic inhibitors of the pd-1/pd-l1 and cd80(b7-1)/pd-l1 protein/protein interactions
Bristol-myers Squibb Company
December 28, 2017 - N°20170369530

The present disclosure provides novel macrocyclic peptides which inhibit the pd-1/pd-l1 and pd-l1/cd80 protein/protein interaction, and thus are useful for the amelioration of various diseases, including cancer and infectious diseases.
Novel compound and antiviral agent containing same as active ingredient
National University Corporation Chiba University
December 28, 2017 - N°20170368015

An object of the invention is to provide a compound that can be utilized as an antiviral agent, in particular as an anti-rna viral agent, and especially as an anti-rs viral agent. The invention provides a compound indicated by formula (1), wherein r1 each independently represent hydrogen, halogen, hydroxyl, amino, carboxyl, c1-c6 alkyl, c1-c6 alkoxyl, c1-c6 halogenoalkyl, c1...
Peptidomimetic macrocycles and uses thereof
Aileron Therapeutics, Inc.
December 21, 2017 - N°20170360881

Provided herein are peptidomimetic macrocycles and methods of using such macrocycles for the treatment of disorders, for example, for treatment of infectious diseases.
Methods for making novel antigen binding domains
Chimera Bioengineering, Inc.
November 23, 2017 - N°20170336393

The present invention relates generally to the field of making novel antigen binding domains against infectious diseases. The present invention also relates to novel cars that utilize the novel antigen binding domains as an extracellular element. The present invention also relates to use of the novel antigen binding domains as therapeutic agents.
Methods and compositions for the activation of gamma-delta t-cells
American Gene Technologies International Inc.
November 23, 2017 - N°20170335344

The present invention relates generally to methods and compositions for gene therapy and immunotherapy that activate gamma delta t-cells, and in particular, can be used in the treatment of various cancers and infectious diseases.
Nitroimidazole compound, preparation method therefor and use thereof in drug manufacturing
Shanghai Sun-sail Pharmaceutical Science & Technology Co., Ltd.
November 23, 2017 - N°20170334927

A nitroimidazole compound represented by general formula (i) or an optical isomer thereof or a pharmaceutically acceptable salt thereof, and a preparation method therefore, and use thereof in manufacturing drugs for the treating infectious diseases caused by mycobacterium tuberculosis. Specific groups in general formula (i) are as defined in the specification.
Infectious Diseases Patent Pack
Download 108+ patent application PDFs
Infectious Diseases Patent Applications
Download 108+ Infectious Diseases-related PDFs
For professional research & prior art discovery
inventor
  • 108+ full patent PDF documents of Infectious Diseases-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Dosage and administration of non-fucosylated anti-cd40 antibodies
Seattle Genetics, Inc.
November 23, 2017 - N°20170333556

This invention relates methods of using a non-fucosylated anti-cd40 antibody for treatment of cancer and chronic infectious diseases.
Convergent and enantioselective total synthesis of communesin analogs
Seattle Genetics, Inc.
November 23, 2017 - N°20170333405

Or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof, wherein r1-r8 and m, n, r, s, t, and u are as defined herein, is provided. Methods of making such compounds are also disclosed as are methods for the treatment of cancer, various infectious diseases, and abnormal cardiovascular function.
Recombinant viral vectors
International Aids Vaccine Initiative
November 16, 2017 - N°20170327544

The present relation relates to recombinant vesicular stomatitis virus for use as prophylactic and therapeutic vaccines for infectious diseases of aids. The present invention encompasses the preparation and purification of immunogenic compositions which are formulated into the vaccines of the present invention.
Compositions and methods for the treatment of mucositis
Cellix Bio Private Limited
November 16, 2017 - N°20170327482

The invention relates to the compounds of formula i, formula ii, formula iii, formula iv, formula v, formula vi, formula vii and formula viii, or its pharmaceutical acceptable polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula i, formula ii, formula iii, formula iv, formula v, formula vi, formula vii and ...
Method of preparing mirabilitum praeparatum by pure strain fermentation and its applications
Cellix Bio Private Limited
November 16, 2017 - N°20170326187

The present invention involves a method of preparing mirabilitum praeparatum by pure strain fermentation and its application in treating infectious and inflammatory diseases, as well as health products and cosmetics. The method involves blending the ripe fruit (watermelon) of citrullus lanatus (thumb.) matsumu. Et nakai with mirabilite (na2so4. 10h2o) according to a certain ratio as culture media and ...
Phosphoramidite synthones for the synthesis of self-neutralizing oligonucleotide compounds
Zata Pharmaceuticals, Inc.
November 09, 2017 - N°20170320902

Compositions and compounds having nucleoside phosphoramidites, and methods of making the same are provided. The compounds can also have one or more amino groups that each can be positively charged. The compounds described permit facile attachment of certain neutralizing moieties with positive charges at their terminal ends on the backbones of oligonucleotides. The compounds can be used for the treatment ...
Targeted conjugates and particles and formulations thereof
Zata Pharmaceuticals, Inc.
November 02, 2017 - N°20170312245

Nanoparticles and microparticles, and pharmaceutical formulations thereof, containing conjugates of an active agent such as a therapeutic, prophylactic, or diagnostic agent attached to a targeting moiety, such as a somatostatin receptor binding moiety, via a linker have been designed. Such nanoparticles and microparticles can provide improved temporospatial delivery of the active agent and/or improved biodistribution. Methods of making the ...
Monitoring method, information processing apparatus, information processing system, and non-transitory computer readable medium
Sysmex Corporation
October 26, 2017 - N°20170309148

The present invention provides a monitoring method for infectious diseases. The monitoring method includes: obtaining disease information from a plurality of medical facilities 131, 132, 133, and 134; determining the disease occurrence status for each medical facility based on the disease information and a first criterion related to the disease occurrence status at the medical facility; and generating first area alarm information related to ...
Loading